Lasco, Medimpax and GSK are among those to receive manufacturing and supply deals under the J$3.3bn ($37m) worth of contracts issued by the Jamaican Government.
Active pharmaceutical ingredient production will be the driving factor behind a predicted boom in the pharmaceutical contract manufacturing market, according to Visiongain.
Since the publication of this article, in-PharmaTechnologist.com has been in touch with Health Canada to find out that the "updates" to the guidance document were actually to the font, not to the regulations. Health Canada launched no disclaimer...
The European Commission (EC) has made changes to its GMP guidelines in order to align them more closely with the pharmaceutical quality system described in ICH Q10.
Outsourcing-Pharma.com brings you a round-up of the latest contract manufacturing facility additions, including news from Boehringer Ingelheim, Cambridge Major Laboratories, and B. Braun Group.
Novartis expects to resume shipping drugs made at its Nebraska, US plant by the end of the year and is on track to fix other quality issues at Sandoz sites hits with 483s in 2011.
Outsourcing-Pharma.com presents a low-down of the latest chops and changes in the world of pharma and biopharma consultancy, including news from PM Group, MedCap and BioBridges.
US regulators approve cancer drugs faster than other medications and much faster than their European counterparts according to a new survey by the Tufts Center for the Study of Drug Development.
US CDMO DPT Labs has not done enough to investigate sterility failures observed during a March inspection according to the Food and Drug Administration (FDA) which wants a ‘comprehensive evaluation’ of sterile drug operations.
Outsourcing-Pharma.com presents its weekly round-up of the latest career changes in the pharmaceutical industry, including news from RSP, CMC Biologics and the NIH.
Worries about increasing regulatory scrutiny and penalties top the list of API and drugmaker concerns about supply chains according to a survey by contract distributor UPS.
Automated drug accountability systems are becoming “the norm” in clinical trials because they can improve compliance and cut working time drastically, according to Cenduit.
Higher demand for clinical services drove growth at Catalent in fiscal Q4, offsetting falling European demand for injectables and flat oral delivery technology sales.
A new non-glycosolated protein production method using E.coli can cut manufacturing costs by up to 50 per cent as well as speeding up the process, according to researchers at the University of Arkansas.
